corpus.blog
41554 blogs · 4,417,066 posts Claim your blog
Record · corpus.blog/posts/01a0875e-1bb1-7222-9d70-4625dc07d33d

Johns Hopkins mKRAS Vaccine Trial Strengthens The Case For Elicio's ELI-002

chaotropy.com · published 9 March 2026

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at chaotropy.com Wayback capture
0blogs citing
First cited
—
Most recent
—
Rank this month
not ranked
Links from this post
13
Words captured
2,469

Cited by

No blog we hold has cited this post yet.

Links from this post

Link
Host
https://elicio.com/investors/
elicio.com
https://www.nature.com/articles/s41467-026-68324-4
nature.com
https://clinicaltrials.gov/study/NCT04117087
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT05726864
clinicaltrials.gov
https://chaotropy.substack.com/p/elicios-therapeutic-vaccine-for-pancreatic
chaotropy.substack.com
https://chaotropy.substack.com/p/monte-carlo-simulation-of-elicios
chaotropy.substack.com
https://www.nature.com/articles/s41591-025-03876-4
nature.com
https://elicio.com/press_releases/elicio-therapeutics-reports-eli-002-7p-achieved-robust-mkras-specific-t-cell-responses-in-99-of-evaluable-patients-in-ongoing-phase-2-amplify-7p-trial/
elicio.com
https://www.nature.com/articles/nature24462
nature.com
https://aacrjournals.org/clincancerres/article/27/18/5084/671639/Identification-and-Validation-of-T-cell-Receptors
aacrjournals.org
https://elicio.com/press_releases/elicio-therapeutics-reports-robust-t-cell-responses-across-diverse-hla-backgrounds-in-ongoing-phase-2-amplify-7p-trial-2/
elicio.com
https://elicio.com/press_releases/elicio-therapeutics-reports-antigen-spreading-to-patient-specific-neoantigens-beyond-mkras-in-ongoing-phase-2-amplify-7p-trial/
elicio.com
https://elicio.com/press_releases/elicio-therapeutics-reports-third-quarter-2025-financial-results-and-provides-corporate-updates/
elicio.com